The study found bile production is affected by how quickly blood enters the liver via the "portal" vein from the intestine.

Patents covering BioVie’s terlipressin liquid formulation now secured in the United States, India, Japan and Chile, and are pending in eight additional markets Liquid formulation has demonstrated room ...

Biomarker NBR1 shows promise in predicting liver cancer patients' response to immunotherapy, potentially improving treatment ...

Liver function discovery may pave the way for improved treatments of cardiovascular diseases, offering new insights into ...